TGFB1 and rheumatoid arthritis: Pinto-Tasende et al. reported that synovial TGF-β1 immunofluorescence reactivity was significantly higher in patients with early psoriatic and rheumatoid arthritis, where it predicted the later need for biologic therapy [48].